Stocks and Investing
Stocks and Investing
Mon, March 27, 2023
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
Fri, March 24, 2023
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
Arthur He Maintained (BCAB) at Strong Buy with Decreased Target to $17 on, Mar 24th, 2023
Arthur He of HC Wainwright & Co., Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Decreased Target from $20 to $17 on, Mar 24th, 2023.
Arthur, nor any peers, have made any analyst calls on BCAB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources